TP53 and central nervous system cancer: The genomic profiling of tumor tissues from cervical spine metastases (a glioma-specific 131-gene and 4- chromosome panel) identified pathogenic mutations in TP53 and potentially damaging mutations in other genes (Table 1, above TP53).